Six-Month Clinical Data Demonstrate Restoration of Cone-Mediated Vision in Pediatric LCA5 Patients, with Sensitivity Improvements Reaching Normal ...

Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...

Six-month data from adult Cohort 4 show structural and functional improvements and a favorable safety profile; early safety data from pediatric ...

Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, announced the completion of the adult dose escalation portion of the STELLAR phase 1/2 clinical trial ...

Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced the completion of the adult dose escalation portion of the STELLAR Phase 1/2 clinical ...

Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ...

An investigative team evaluated the real-world performance of faricimab in managing patients with AMD and subretinal ...

Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...

Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...